Results 81 to 90 of about 29,889 (292)
Transfusion therapy remains the main treatment for patients with severe haemoglobinopathies, but can cause adverse reactions which may be classified as immediate or delayed. The use of targeted prevention with drugs and treatments of blood components in selected patients can contribute to reducing the development of some reactions.The aim of our study ...
Francesco, Bennardello +9 more
openaire +2 more sources
This cross‐sectional study analyzed data from 9331 participants aged 24–97 to characterize age‐ and sex‐related physiological trajectories of complete blood cell count (CBC) parameters and derived inflammatory indices. Key findings encompassed age‐related declines in red blood cell and platelet counts, elevations in RDW‐CV indices and monocyte ...
Xiangyi Ma +8 more
wiley +1 more source
Estudo dos incidentes transfuncionais imediatos ocorridos no Hospital Universitário da Universidade Federal de Santa Catarina (HU-UFSC) [PDF]
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Costa, Fernanda Vicente da
core
Allogeneic hematopoietic stem cell transplantation remains a potentially curative therapy for many hematological malignancies; however, its success is significantly limited by acute graft‐versus‐host disease (aGVHD), a leading cause of post‐transplant morbidity and mortality in which endothelial dysfunction plays a central role.
Katarina Klinar, Helena Podgornik
wiley +1 more source
Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion
A blood transfusion is an acute intervention, implemented to solve life and health-threatening conditions on a short-term basis. However, blood transfusions have adverse events, some of them potentially related to immune modulation or to a direct transmission of infectious agents (e.g. cytomegalovirus).
Daniel, Simancas-Racines +3 more
openaire +3 more sources
Costs and consequences of over‐investigation of minor transfusion reactions
Background Adverse transfusion events create a direct cost burden on the healthcare system through increased morbidity, mortality, extra investigations for diagnosis, patient treatment and increased use of hospital resources.
Philip Crispin +5 more
core +1 more source
Staff Responsibilities Flowchart for reporting a Transfusion Reaction
Each blood product transfused carries a small risk of an acute or late adverse event. The most common immediate adverse reactions are fever, chills and urticaria. The most potentially significant reactions include acute and delayed haemolytic transfusion
Blood Transfusion
core
ABSTRACT Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, is a major complication in women with epithelial ovarian cancer (EOC). We aimed to develop and externally validate an early postoperative risk score to identify EOC patients at increased risk of VTE after debulking surgery.
Qiu‐Lin Cui +6 more
wiley +1 more source
Background: Use of blood and its components is lifesaving. However, their use is often associated with adverse events. Objective: To analyze the pattern of adverse reactions associated with transfusion of blood and its components in pediatric and ...
Kunal J Ghataliya +6 more
doaj +1 more source
SHOT is affiliated to the Royal College of PathologistsTransfusion of blood components in the UK remains remarkably safe, with the risk of death 0.0027 and risk of major morbidity 0.0396 per 1000 components issued respectively.
Serious Hazards of Transfusion (SHOT)
core

